Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities.
about
Exotoxins of Staphylococcus aureusPanton-Valentine leukocidin genes in Staphylococcus aureusPathogenesis of methicillin-resistant Staphylococcus aureus infectionResidues Essential for Panton-Valentine Leukocidin S Component Binding to Its Cell Receptor Suggest Both Plasticity and Adaptability in Its Interaction SurfacePathogenesis of Staphylococcus aureus abscessesDetection of Alpha-Toxin and Other Virulence Factors in Biofilms of Staphylococcus aureus on Polystyrene and a Human Epidermal ModelStaphylococcal leukotoxins trigger free intracellular Ca(2+) rise in neurones, signalling through acidic stores and activation of store-operated channelsStaphylococcal Panton-Valentine leucocidin as a major virulence factor associated to furuncles.Distinction between pore assembly by staphylococcal alpha-toxin versus leukotoxins.Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore.alpha-Hemolysin, gamma-hemolysin, and leukocidin from Staphylococcus aureus: distant in sequence but similar in structure.Differential regulation of staphylococcal virulence by the sensor kinase SaeS in response to neutrophil-derived stimuli.The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.Stochastic assembly of two-component staphylococcal gamma-hemolysin into heteroheptameric transmembrane pores with alternate subunit arrangements in ratios of 3:4 and 4:3.Kineret®/IL-1ra blocks the IL-1/IL-8 inflammatory cascade during recombinant Panton Valentine Leukocidin-triggered pneumonia but not during S. aureus infectionIdentification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection.A histidine-to-arginine substitution in Panton-Valentine leukocidin from USA300 community-acquired methicillin-resistant Staphylococcus aureus does not impair its leukotoxicity.Comparative genomics and transduction potential of Enterococcus faecalis temperate bacteriophages.Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics.Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin.The bicomponent pore-forming leucocidins of Staphylococcus aureusEsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections.Host- and tissue-specific pathogenic traits of Staphylococcus aureus.Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease.Global changes in Staphylococcus aureus gene expression in human blood.Detection and quantification of Panton-Valentine leukocidin in Staphylococcus aureus cultures by ELISA and Western blotting: diethylpyrocarbonate inhibits binding of protein A to IgGRelative contribution of Panton-Valentine leukocidin to PMN plasma membrane permeability and lysis caused by USA300 and USA400 culture supernatantsFlow cytometric determination of Panton-Valentine leucocidin S component binding.Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1.Fatal S. aureus hemorrhagic pneumonia: genetic analysis of a unique clinical isolate producing both PVL and TSST-1.Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils.Acute septic arthritis.Development of a triplex real-time PCR assay for detection of Panton-Valentine leukocidin toxin genes in clinical isolates of methicillin-resistant Staphylococcus aureus.Role of pore-forming toxins in bacterial infectious diseases.Methicillin-resistant Staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial development.The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptorsCharacterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood.Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.Leucotoxic activities of Staphylococcus aureus strains isolated from cows, ewes, and goats with mastitis: importance of LukM/LukF'-PV leukotoxin.Variability of antibiotic susceptibility and toxin production of Staphylococcus aureus strains isolated from skin, soft tissue, and bone related infections.
P2860
Q24550718-8160AA04-9EC3-4184-99FE-EB92569DE3D2Q24603808-254E743C-7291-409C-A334-0901E7388AAAQ24657579-C6642337-071E-4EB6-8AF4-93671CDC7A13Q27682292-76D4AEB1-95CB-4445-9A24-942D3128B87FQ28080781-CA2A1787-626A-420D-AA47-67C4918B1658Q28552176-B4DDC686-F2BB-4FC2-A8DD-5B47F3D7A7FBQ28703620-0CAA944E-3D21-42B9-A64D-83CDDA03C904Q30155449-74B363FF-F893-42D1-8AF7-DDB19D70DE4DQ30157977-8473B908-3802-4095-82E6-3C4A96D4F010Q30167424-12C6C9ED-D018-47A4-B49D-DCF47BAF19F0Q30176339-9098D297-A6FE-40C4-AACB-0CE92E07D6BEQ30361924-D8F0E47C-2D5B-4379-A281-DFEC918EAAC8Q30415990-B09E12CF-AA05-4881-8EE4-B2F80910F644Q30712777-91A9CEFE-1962-433F-8DD8-CCA9636D07A9Q31164686-88255EFE-AED6-4DED-9A79-8FB7D92963A7Q33244198-29394CDE-F677-4680-9590-6A4DFDA668BCQ33557856-1EFACB92-63AA-40A7-BBC8-DE187037714DQ33616966-BE1A4262-4D10-46F3-81EC-1D95D68A7052Q33641315-D0744CC5-4D5C-4DB5-B9B2-0AA1084DDAD3Q33715923-00D8ABDC-9383-48BE-B49F-080653228240Q33743499-335AEF4A-C02B-4074-9400-80D4F49721E6Q33762320-F526BDBA-7D6D-417B-B5FF-CF4129500083Q33855767-FD41900F-524A-4860-BEA2-752D7B260EEBQ33858913-9AD400A5-B7C7-4C75-BDD6-0AD2B2A8D02AQ33883340-C80FEC8B-AC7B-445E-B624-6A6BA94C2115Q33886780-DE5C3F2B-2A57-497C-A285-2AEC1C99AA5DQ33905654-1B69F186-8D39-48DD-ADD6-F3772F8BD3F0Q34006878-0EECC593-3810-483B-8DBB-A81EB87AB008Q34007530-21F937B9-CAF2-42F5-AE95-819DE9085354Q34081474-B00F365E-8ECA-47D9-BED9-707E45878C11Q34097530-95303D6E-A444-4537-B0D5-3D65C069A4C9Q34102880-71946EC2-36FC-40E6-8167-BC012E30F17FQ34231860-9C4FEB38-37A9-400F-8D0B-594F0209ECE2Q34346202-326BB3B8-F83F-4441-920E-81D92786FAC6Q34407240-177BD375-73B3-490D-82DC-8882DA881AFBQ34495209-1A94E8F3-2E92-4CC4-88C2-E9FB14DB57EAQ34545013-183C2208-6474-4348-B7E0-ED4EFAE36544Q34769869-7C7DF24C-4E69-4E76-867D-A2E23D3FE43DQ34779287-50B1BCBF-0BBB-4239-8125-00DA5D5A3FA3Q34909005-207D7DFA-7824-4159-B532-B7467ECFF493
P2860
Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities.
description
1995 nî lūn-bûn
@nan
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Panton-Valentine leucocidin an ...... fferent biological activities.
@ast
Panton-Valentine leucocidin an ...... fferent biological activities.
@en
type
label
Panton-Valentine leucocidin an ...... fferent biological activities.
@ast
Panton-Valentine leucocidin an ...... fferent biological activities.
@en
prefLabel
Panton-Valentine leucocidin an ...... fferent biological activities.
@ast
Panton-Valentine leucocidin an ...... fferent biological activities.
@en
P2093
P2860
P1476
Panton-Valentine leucocidin an ...... fferent biological activities.
@en
P2093
Finck-Barbançon V
Supersac G
P2860
P304
P407
P577
1995-10-01T00:00:00Z